Dr. Raju Mohindra (Dawa Group Chairman), Dr. Ajay Patel (Dawa Group Managing Director) and Mrs. Reema Mohindra (Dawa Group Finance Director) participated at the 1st East African Vaccine Symposium (Vaccine production in Africa for Africa) that brought investors and public health officials together to explore the opportunities for regional vaccine production.
The East African Vaccine Symposium, hosted by the GHP and the African-German Business Association (Afrika-Verein) with the support of Merck, GFA Consulting, Bosch, and FEAPM on 17th and 18th April 2018 in Arusha, Tanzania, provided an excellent opportunity to develop the business and public health case for regional vaccine production.
Human vaccines are amongst the most important medical tools currently available. They can prevent a number of infectious diseases and can hamper countries’ economic and social development. Therefore, the region requires effective and accessible vaccines to mitigate the social and economic damage caused by infectious diseases. German healthcare industries can play a crucial role in facilitating vaccine manufacturing by providing expertise from a range of sectors such as life sciences, processing, and medical technologies to make vaccine manufacturing in East Africa possible.
This symposium therefore aimed at highlighting possible and beneficial cooperation between countries, sectors, and organisations that is essential for ambitious projects such as regional vaccine manufacturing. Stakeholders from the public and the private sector thereby seek to combine their strengths in order to overcome the current challenges for East African health sectors such as lack of investment and infrastructure gaps.
Dr. Raju Mohindra, Mrs. Reema Mohindra and Dr. Ajay Patel